|
Re: China, China, China
|
2
|
Resverlogix Corp.
|
Aug 31, 2017 09:15PM
|
|
Re: AACR 2018
|
2
|
Zenith Epigenetics
|
Mar 06, 2018 01:15PM
|
|
Re: Covid study
|
2
|
Resverlogix Corp.
|
Feb 13, 2024 10:56AM
|
|
Vote reminder
|
2
|
Zenith Epigenetics
|
Oct 19, 2023 12:50PM
|
|
Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study
|
2
|
Resverlogix Corp.
|
Jun 22, 2020 06:27PM
|
|
Re: AACR 2018
|
2
|
Zenith Epigenetics
|
Mar 06, 2018 01:24PM
|
|
Re: Demoralizing....
|
2
|
Resverlogix Corp.
|
Sep 22, 2017 04:01PM
|
|
Re: Share Liquidity
|
2
|
Zenith Epigenetics
|
Dec 17, 2017 03:06PM
|
|
Re: CANTOS and CIRT
|
2
|
Resverlogix Corp.
|
Nov 14, 2017 06:21PM
|
|
CRISPR vs. BET inhibitors
|
2
|
Resverlogix Corp.
|
Jan 10, 2016 10:19AM
|
|
Re: While we wait, outside items that may be of interest
|
2
|
Resverlogix Corp.
|
Aug 27, 2017 11:11AM
|
|
Re: Corporate Update Webcast and Conference Call December 16, 2021 @ 2 PM MST
|
2
|
Resverlogix Corp.
|
Dec 13, 2021 12:46PM
|
|
Re: Insider activity, grants of rights and an option exercise at 75 cents
|
2
|
Resverlogix Corp.
|
Jun 17, 2019 01:33PM
|
|
Re: got this from Sarah yesterday..
|
2
|
Resverlogix Corp.
|
Mar 04, 2022 05:58PM
|
|
Re: Resverlogix & Zenith, hmmm...
|
2
|
Resverlogix Corp.
|
May 16, 2015 09:45AM
|
|
Re: Should I do a blog posting about Resverlogix?
|
2
|
Resverlogix Corp.
|
Apr 30, 2016 09:33AM
|
|
Re: Merck lands positive PhIII for its CETP drug anacetrapib
|
2
|
Resverlogix Corp.
|
Jun 27, 2017 01:25PM
|
|
Re: Why have we not heard more about CURATE-AI?
|
2
|
Zenith Epigenetics
|
Mar 25, 2021 11:12AM
|
|
Re: Long Covid
|
2
|
Resverlogix Corp.
|
Jan 21, 2024 11:31AM
|
|
Re: Liquidity
|
2
|
Zenith Epigenetics
|
Aug 03, 2019 02:56PM
|
